Skip to main content
Equibles

Paul Fonteyne

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Paul Fonteyne

Earlier roles on record: Board Member at Apellis Pharmaceuticals, Inc. until May 14, 2026. Apellis Pharmaceuticals, Inc. reported in an 8-K filed May 14, 2026 that Paul Fonteyne resigned as member of the Board of Directors of the Company and any committee thereof, effective May 14, 2026.

“Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.”
Apellis Pharmaceuticals, Inc. Form 8-K, filed May 14, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Apellis Pharmaceuticals, Inc.

    Board Member

    SEC 8-K

    2020-04-02–2026-05-14

Company network

Recorded roles and call appearances connecting this person to public companies.

Apellis Pharmaceuticals, Inc.

Board Member

2020-04-02–2026-05-14

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.